SCHEMBL31229527

SCHEMBL31229527

C1COCCN2CCOCCN(CCOCCO1)CCOCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.50
MGLL Q99685 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.41
CA12 O43570 6/20 0.40
CA7 P43166 1/20 0.40
CA14 Q9ULX7 1/20 0.40
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
CA1 P00915 5/20 0.38
CA9 Q16790 5/20 0.38
CA2 P00918 4/20 0.38
HSD17B10 Q99714 1/20 0.38
PDK1 Q15118 2/20 0.35
PDK2 Q15119 2/20 0.35
PDK3 Q15120 2/20 0.35
FAAH O00519 1/20 0.35
PHGDH O43175 1/20 0.35
ALDH2 P05091 1/20 0.35
USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25928 1.00 TTR (0.50) TTRMGLLSMN1; SMN2CA12CA7
SCHEMBL11583577 1.00 TTR (0.50) TTRMGLLSMN1; SMN2CA12CA7
SCHEMBL27619 1.00 TTR (0.50) TTRMGLLSMN1; SMN2CA12CA7
SCHEMBL11552627 1.00 TTR (0.50) TTRMGLLSMN1; SMN2CA12CA7
SCHEMBL11554965 1.00 TTR (0.50) TTRMGLLSMN1; SMN2CA12CA7
SCHEMBL27017 1.00 TTR (0.50) TTRMGLLSMN1; SMN2CA12CA7
Hydrochloric Acid SCHEMBL11584373 0.96 TTR (0.46) TTRMGLLSMN1; SMN2CA12CA7
Hydrochloric Acid SCHEMBL15639418 0.96 TTR (0.46) TTRMGLLSMN1; SMN2CA12CA7
SCHEMBL19209486 0.96 TTR (0.46) TTRMGLLSMN1; SMN2CA12CA7
SCHEMBL10599432 0.96 MGLL (0.47) TTRMGLLSMN1; SMN2CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4467631-B1 MIXTURE COMPRISING EUROPIUM-ORGANIC COORDINATION COMPOUND AND METHOD FOR PRODUCING THE SAME BEEOLED GMBH (DE) 2025-05-14 EP disclosed
US-20250002515-A1 MIXTURE COMPRISING EUROPIUM-ORGANIC COORDINATION COMPOUND AND METHOD FOR PRODUCING THE SAME BEEOLED GMBH (DE) 2025-01-02 US disclosed
US-20240392185-A1 METAL-ORGANIC COORDINATION COMPOUND AND METHOD FOR PRODUCING THE SAME BEEOLED GMBH (DE) 2024-11-28 US disclosed
EP-4467551-A1 METAL-ORGANIC COORDINATION COMPOUND AND METHOD FOR PRODUCING THE SAME beeOLED GmbH (DE) 2024-11-27 EP disclosed
EP-4467631-A1 MIXTURE COMPRISING EUROPIUM-ORGANIC COORDINATION COMPOUND AND METHOD FOR PRODUCING THE SAME beeOLED GmbH (DE) 2024-11-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250002515-A1 MIXTURE COMPRISING EUROPIUM-ORGANIC COORDINATION COMPOUND AND METHOD FOR PRODUCING THE SAME ALG3, ORC3, EMC1 TTR 1002/4885MGLL 2103/4885SMN1; SMN2 2665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.